GHK-Cu (Copper Peptide)
Copper-Binding Tripeptide | Skin & Tissue Remodeling Studies
₱2000.00₱1600.00
BUY NOW |
|---|
Third-party Tested | Free Shipping Nationwide | COA Verified |
Active Batch | Purity |
GHKCU-SL3R18 | > 99.7% |
All products are third-party tested by our manufacturer before release and are submitted again to an independent third-party laboratory upon arrival in the Philippines. This additional testing helps verify identity, purity, heavy metals, residual solvents, microbial safety, and overall batch quality before distribution. If independent testing shows purity below 99%, we offer a money-back guarantee.
GHK-Cu, also known as copper tripeptide-1 or glycyl-L-histidyl-L-lysine copper complex, is an investigational copper-binding peptide commonly discussed in skin, hair, wound-healing, tissue-repair, and regenerative research. It is a naturally occurring tripeptide complex associated with copper signaling and is often studied for its possible relationship to extracellular matrix remodeling, collagen-related pathways, antioxidant response, and tissue-repair mechanisms. PubChem lists GHK-Cu as a copper peptide complex with the formula C₂₈H₄₈CuN₁₂O₈.
Unlike metabolic peptides such as tirzepatide, GHK-Cu is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Instead, scientific interest centers on copper-peptide signaling, skin-quality research, hair and follicle models, wound-healing investigation, connective-tissue support, inflammation-response pathways, and broader regenerative study. Reviews describe GHK-Cu as a peptide of interest in human skin research and tissue-regenerative mechanisms, while still emphasizing the need to avoid overextending claims beyond the available evidence.
Potential research interests observed in studies
Skin and collagen research
GHK-Cu is widely discussed in skin-related research involving collagen support, dermal remodeling, skin appearance, elasticity, and extracellular matrix activity. This is one of the most common areas where copper peptides are studied.
Wound-healing and tissue-repair models
Research interest often focuses on wound-healing pathways, tissue-repair signaling, and recovery-related mechanisms. Reviews describe GHK-Cu as a copper peptide associated with regenerative and protective actions in skin and tissue models.
Hair and follicle research
GHK-Cu is frequently discussed in relation to scalp, follicle, and hair-support research. These discussions are mainly investigational and should not be presented as proven treatment outcomes.
Connective-tissue support research
Because GHK-Cu is associated with matrix remodeling and collagen-related pathways, it is often studied in broader connective-tissue and tissue-quality research contexts.
Copper-peptide signaling
GHK-Cu is studied as a copper-binding peptide complex, which makes it relevant to research involving copper transport, peptide-metal coordination, cellular signaling, and redox-related mechanisms.
Antioxidant and inflammation-response research
Scientific discussion around GHK-Cu often includes antioxidant response, inflammatory signaling, and tissue-stress pathways. These findings should be understood as research interests, not confirmed clinical benefits.
Cosmetic and dermatology research interest
GHK-Cu has a long history of discussion in cosmetic science, especially around skin-aging, texture, and appearance-related research. Public interest has grown, but many consumer-facing claims still exceed what controlled clinical evidence can firmly establish.
Stable topical-research interest
GHK-Cu is commonly discussed in topical and cosmetic research contexts because of its copper-peptide identity and skin-focused study history. Injectable or unapproved human use should not be implied or promoted.
Limitations and risks observed or discussed
Human clinical evidence is still limited
Although GHK-Cu has more cosmetic and skin-related research history than many newer peptides, broad human claims around skin regeneration, hair growth, anti-aging, wound healing, or systemic benefits still require stronger controlled clinical evidence.
Not an approved medication for disease treatment
GHK-Cu should not be marketed as a treatment for wounds, hair loss, skin disease, scarring, inflammation, injury recovery, or any medical condition.
Route of use matters
Topical cosmetic discussion is different from injection or systemic exposure. Research-grade or unapproved peptide products should not be used in humans, especially by injection.
Unknown long-term safety profile for unapproved use
Long-term safety, dose-response, interaction risks, contamination risk, and appropriate populations are not fully established for unapproved or research-grade GHK-Cu products.
Possible irritation or sensitivity
Copper peptide products may cause irritation, sensitivity, redness, or other local reactions in some topical-use contexts. These risks may vary depending on concentration, formulation, and individual skin response.
Copper-related formulation concerns
Because GHK-Cu involves copper complexation, improper formulation, instability, concentration errors, or contamination may affect product quality and safety.
Possible risks from unregulated products
Products sold online as research chemicals may carry risks related to contamination, inaccurate concentration, mislabeling, sterility issues, or lack of regulated manufacturing oversight.
Claims may exceed the evidence
Many online claims around “anti-aging,” “hair growth,” “scar repair,” “skin regeneration,” or “wound healing” go beyond what has been proven in controlled human trials.
Website-safe closing line
GHK-Cu is scientifically interesting for copper-peptide signaling, skin, hair, wound-healing, connective-tissue, and regenerative research, but broad human safety and effectiveness claims remain insufficiently established. GHK-Cu should not be marketed as a treatment for any medical condition, and unapproved human use should be avoided. Sterile Labs products are strictly for research use only.
